Better Science, Better Health: New Trial Pathways and Better Patient Data Photos: VIP Dinner 20th October 2014 Royal College of Physicians Better Science Better Health conference 21st October 2014 Royal College of Physicians Videos: Better Science, Better Health Edward [...]
Better Science, Better Health: New Trial Pathways and Better Patient Data Presentations: New Pathways for Development and Better Patient Outcomes Stephen Whitehead, Chief Executive, ABPI New Pathways & New Sources of Evidence. What do we need? Marc Trusheim, MIT Sloan School of Management Finn Børlum Kristensen, Executive Director, Eunetha Jillian Oderkirk, [...]
Better Science, Better Health: New Trial Pathways and Better Patient Data In collaboration with: This conference is supported by: Research Partners:
Better Science, Better Health: New Trial Pathways and Better Patient Data Speakers: Edward Abrahams President, Personalized Medicine Coalition Ifty Ahmed CEO, Pow Health Mohammad Al-Ubaydli CEO, Patients Know Best® James Anderson Director of EU Industry & External Partnerships, GSK [...]
Better Science, Better Health: New Trial Pathways and Better Patient Data Agenda: October 20th, 2014 14:00 IMI Round Table (by invitation) 19:00 VIP Dinner (by invitation) October October 21st, 2014, London – Royal College of Physicians 8:30 Registration 9:00 Introduction, Sir Richard Thompson, Immediate Past President, Royal College of Physicians 9:05 [...]
October 21st, 2014CONFERENCE REPORT: On October 21st, an international group of experts was invited to the Royal College of Physicians in London to discuss how new clinical regulatory pathways, sources of evidence, and evolving data on real world patients can be used both to expedite the development of drugs and improve their quality and access. Broadly called “MAPPs” (Medicines Adaptive Pathways to Patients), the goal is to speed patient access to needed therapies while increasing the productivity of industry R&D spending.